Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
Medtronic Scoops Up NJ-based Tyrx for $160M 01/06/14 New York
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
Catabasis Scores $32M Series B Round With IPO in Sight 11/15/13 Boston
Catabasis Pharmaceuticals Receives $32,400,000 Series B Financing 11/14/13 Boston
Aerie Gets Lukewarm Reception, Cuts IPO Price to $10 Per Share 10/25/13 New York
Ophthotech Prices IPO at $22 Per Share, Reels in $167M 09/24/13 New York
Aerie Pharma Eyes $58M IPO For Glaucoma Drug Push 09/18/13 New York
Biotech VCs, Stung by Startup Returns, Elbow into Royalty Financing 08/16/13 Boston
Ophthotech Eyes $85M IPO With Late-Stage Clinical Trial in Sight 08/15/13 New York
FDA Clears New Version of Tyrx’s Infection-Fighting Pacemaker Sleeve 07/09/13 New York
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Ophthotech Nabs $175M To Fund Late-Stage Trial For Eye Drug 05/29/13 New York
NanoString Technologies Maneuvers In Line for $86M IPO 05/20/13 Seattle
NanoString Technologies Garners $15,300,000 Series E Financing Round 12/03/12 Seattle
Pearl Therapeutics Secures $65,000,000 Series D Round 11/13/12 San Francisco
Cardiac Dimensions Nabs $5.8M for Heart Failure Device 09/12/12 Seattle
NanoString Makes IPO Prep Move, Adds Finance Vet to Board 07/18/12 Seattle
Sientra Secures $65,000,000 Series C Round 03/29/12 San Diego
Shire Shells Out $100M to Buy Ferrokin Biosciences 03/15/12 San Francisco
Clarus Ventures Adjusts to Unpredictable Biotech World 01/20/12 Boston
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More 01/06/12 San Diego
Catabasis Pharmaceuticals Garners $8,000,000 Series A Round 12/13/11 Boston
Momenta Gets a Steal on Promising Scientific Asset from Once-Hot Virdante 12/07/11 Boston
Best Buy Picks Up MindShift, Termeer Funds NanoString, Basho Adds $5M More, & More Boston-Area Deals News 11/09/11 Boston
NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics 11/07/11 Seattle
NanoString Technologies Obtains $20,000,000 Series D Funding 11/07/11 Seattle
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment 10/20/11 Boston
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies 10/11/11 San Francisco
Cleave Biosciences Receives $42,000,000 Series A Financing Round 10/11/11 San Francisco
Page 1 of 4 next page »